BeiGene USA, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma (NCT03150862) | BeiGene USA, Inc. | 2017-07-24 |
Track BeiGene USA, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.